Aug 31, 2026 05:08PM
Aug 4, 2026 09:05AM
Aug 3, 2026 05:42AM
Jul 29, 2026 05:42PM
Jul 29, 2026 05:42PM
Jul 29, 2026 05:28PM
Jul 15, 2026 06:56AM Johnson & Johnson beats estimates but shares dip
Jul 15, 2026 06:21AM
Jul 15, 2026 06:20AM
Jul 15, 2026 03:00AM
Jun 30, 2026 09:00AM
Jun 26, 2026 08:16AM
May 27, 2026 04:22PM
Apr 27, 2026 08:03AM FDA grants priority review to J&J's IMAAVY for rare blood disorder
Apr 27, 2026 08:03AM
Apr 20, 2026 06:53AM
Apr 15, 2026 07:21AM
Apr 15, 2026 07:10AM
Apr 14, 2026 06:45AM
Apr 14, 2026 06:27AM
Apr 14, 2026 06:22AM Johnson & Johnson (JNJ) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY Guidance
Apr 14, 2026 06:20AM
Apr 14, 2026 02:00AM
Apr 8, 2026 04:43AM
Mar 5, 2026 11:30PM
Mar 2, 2026 04:30PM
Jan 22, 2026 05:12AM
Jan 22, 2026 05:12AM Johnson & Johnson (JNJ) PT Raised to $221 at BofA Securities
Jan 21, 2026 08:28AM
Jan 21, 2026 06:22AM
Jan 21, 2026 06:20AM
Jan 21, 2026 04:00AM
Jan 9, 2026 07:46AM
Dec 29, 2025 08:00AM
Dec 29, 2025 08:00AM Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
Dec 17, 2025 05:27AM
Dec 15, 2025 04:27PM
Nov 17, 2025 08:00AM
Nov 17, 2025 08:00AM
Nov 6, 2025 07:30AM
Nov 6, 2025 07:30AM
Nov 6, 2025 07:30AM FDA approval of CAPLYTA® (lumateperone) has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder
Oct 15, 2025 04:36AM
Oct 14, 2025 07:35AM
Oct 14, 2025 06:26AM
Oct 14, 2025 06:21AM
Oct 14, 2025 06:20AM
Oct 14, 2025 04:00AM
Oct 8, 2025 06:33AM Johnson & Johnson (JNJ) PT Raised to $212 at Goldman Sachs
Oct 5, 2025 08:00PM

1,223,217 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All